Tebao Bio is an innovative biomedical R&D and production enterprise, mainly engaged in the production and sales of R&D, recombinant proteins and their long-term modified drugs. The company focuses on the research and development of immune-related cytokine drugs, and is committed to providing better solutions for major diseases such as viral hepatitis and malignant tumors and immunotherapy. The main products are recombinant human granulocyte stimulating factor injection "Trzin" and recombinant human granulocyte macrophage stimulating factor for injection "Teli".
More peer analysis, the company knows and understands.